Effective Date: November 01, 2024 | Last Updated:
NoahTech, Corp. (“NoahTech,” “we,” “us,” or “our”) is a clinical-stage neuroscience company developing novel regenerative and cognitive enhancement therapies. We are deeply committed to protecting the privacy and security of all personal information entrusted to us — whether from website visitors, clinical trial participants, healthcare providers, or business partners.
This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you:
During clinical trial eligibility screening or participation, we collect protected health information (PHI) under a separate IRB-approved Informed Consent Form and HIPAA Authorization. This includes:
| Purpose | Legal Basis |
|---|---|
| Respond to inquiries and schedule consultations | Legitimate Interest / Consent |
| Evaluate clinical trial eligibility | Explicit Consent + IRB Approval |
| Conduct and manage clinical research | Regulatory Compliance (21 CFR Part 11, ICH-GCP) |
| Improve website functionality | Legitimate Interest |
| Comply with legal obligations | Legal Obligation |
We do not sell your personal information. We may share data with:
Data may be transferred to and processed in the United States and other countries. We implement EU Standard Contractual Clauses (SCCs) and UK International Data Transfer Agreement where required.
We maintain administrative, technical, and physical safeguards including:
We retain personal data only as long as necessary:
You have the right to:
Contact: privacy@noahtech.health
Our services are not directed to individuals under 18. We do not knowingly collect data from children.
We may update this policy. Material changes will be notified via website notice or email.
Data Protection Officer
Email: privacy@noahtech.health
Noah Tech, Corp., 930 S 4th St Ste 209, Las Vegas, NV 89101, USA